Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Androgen deprivation effect on LNCaP prostate cancer cells: time course
PubMed Similar studies GEO Profiles Analyze DataSet
Longitudinal Analysis of Progression to Androgen Independence
PubMed Similar studies Analyze with GEO2R
Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-wide Gene-expression Profiles
PubMed Full text in PMC Similar studies Analyze with GEO2R
Gene expression profiling of hormone resistant prostate cancer
HS to HR progression
Conversion
Androgen receptor antagonist to agonist conversion
Prostate cancer antiandrogen resistance
Mat-Lylu cell line compared to G cell line
Prostate cancer - comparison of androgen-dependent and -independent microdissected primary tumor
Prostate cancer progression after androgen ablation
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Glycosylation regulates the stability of c-MYC
Transcriptome profiles of canonical MED19 LNCaP and control LNCaP cells cultured under androgen deprivation with vehicle or R1881 treatment
Expression data from androgen treated LNCaP cells
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [RNA-seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [ChIP-seq]
PubMed Full text in PMC Similar studies SRA Run Selector
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [CWR22 xenograft]
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome
PubMed Full text in PMC Similar studies
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [CWR22_EPIC]
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [CellLine_EPIC]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on